Zacks.com on MSN2d
CRISPR Therapeutics Stock Falls 34% in a Year: Time to Buy or Sell?
Shares of CRISPR Therapeutics CRSP have lost more than 30% in the past year. Though the stock soared at the onset of 2024, ...
An Entire Book Was Written in DNA—and You Can Buy It for $60
What may be the first commercially available book saved in DNA is the latest example of how consumers might use molecular ...